Concord Medical Services (NYSE:CCM) Stock Price Crosses Above 200 Day Moving Average – Here’s What Happened

Concord Medical Services Holdings Limited (NYSE:CCM) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $4.25 and traded as high as $5.11. Concord Medical Services shares last traded at $5.0790, with a volume of 32,136 shares trading hands.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Concord Medical Services in a research note on Tuesday, May 26th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

Concord Medical Services Trading Up 4.1%

The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 1.33. The business’s 50-day moving average price is $4.83 and its two-hundred day moving average price is $4.25.

Concord Medical Services (NYSE:CCM) last released its quarterly earnings data on Wednesday, April 29th. The company reported ($1.08) EPS for the quarter.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.